ArticlePloS one2013

Embryonic cardiomyocyte, but not autologous stem cell transplantation, restricts infarct expansion, enhances ventricular function, and improves long-term survival.

Leonie E Paulis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.